Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Feb 01, 2024 5:36pm
190 Views
Post# 35858216

RE:RE:RE:RE:RE:RE:RE:RE:RE:Will history repeat?

RE:RE:RE:RE:RE:RE:RE:RE:RE:Will history repeat?

Hey Rev 

Do yourself a favour 
put St on ignore

Life's been much better for me, with that done. 

If he's whining about iDialco, he's obviously desperate for subject matter ( noting that he always needs something to be critical of) 

Fresenius (NXStage) and Outset (Tablo) the market leaders are discovering that the move to Home Dialysis is not happening overnight. Outset for example has lost > 95% of its market value since 2021. 

I like that the SAMI and DIMI development seem to have been slowed or even shelved for now.   I do believe that HD's day will come, but the market isn't ready for it just yet. 

Let's bring home PMX/EAA first and let the HD market catch on and catch up to the innovations built into iDialco products. 

As you say, it won't matter when PMX ( the crown jewel) comes thru in the next 3 to 18 months. 

But iDialco could be a nice cherry on top 3-5 years hence - when it comes time to cash in for a second time, on the yet to fully develop Home market. 


MM 


 

<< Previous
Bullboard Posts
Next >>